Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03168451 · ClinicalTrials.gov registry record · NA
American Indians STOp Smoking by Mobile Phone
A NA study, sponsored by Washington State University.
- Completed
- Registry status
- NA
- Development phase
- 346
- Enrollment target
NCT03168451: Completed NA study, sponsored by Washington State University.
NCT03168451 is a NA study that has completed, run by Washington State University. The registered enrollment target is 346 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03168451, a NA study, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 346 participants
- Enrollment target
Study Summary
In an attempt to reduce smoking-related health disparities, investigators will implement a text messaging-based smoking cessation intervention in collaboration with state quit lines. The approach is based on the successful STOMP (STOp smoking by Mobile Phone) program, a text messaging-based smoking cessation intervention among young Maori adults in New Zealand. Investigators will adapt the STOMP intervention, which will result in a new intervention known as AI STOMP (American Indians STOp smoking by Mobile Phone).The primary aim of the study is to determine the effectiveness of the AI-STOMP intervention in smoking cessation among American Indians.
Primary Outcome
Number of participants who quit smoking while receiving text messages, as measured by self-report at 4 time points over 6 months.
Interventions
- BEHAVIORAL Culturally Tailored Text Messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 346 participants |
| Start Date | 2015-11-30 |
| Est. Completion | 2018-09-01 |
| Phase | NA |
What the finished NCT03168451 record still lists
NCT03168451 is an interventional study that assigns participants to a tested intervention. The registered 346 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 1 intervention - of which Culturally Tailored Text Messages is the first listed.
NCT03168451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03168451 about?
NCT03168451 is a clinical study titled "American Indians STOp Smoking by Mobile Phone". In an attempt to reduce smoking-related health disparities, investigators will implement a text messaging-based smoking cessation intervention in collaboration with state quit lines. The approach is based on the successful STOMP (STOp smoking by Mobile Phone) program, a text messaging-based smoking ...
What is the current status of trial NCT03168451?
This trial is currently completed. It is a NA study. The enrollment target is 346 participants. The study started on 2015-11-30. Estimated completion is 2018-09-01.
What interventions are being tested in trial NCT03168451?
The interventions under investigation include: Culturally Tailored Text Messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT03168451?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03168451's enrollment target sits among peer trials
346 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267886 · 346 participants · Phase 4
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
- NCT06705842 · 346 participants · Phase 4
APPI-Cost Trial for Perforated Appendicitis
- NCT06932887 · 346 participants · Phase 3
The Beat Pain Better Trial
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI